retatrutide active ingredient for weight loss: Study shows 30% body weight loss Retatrutide (LY3437943) | GCGR/GIPR/GLP-1R Agonist
Description
Inject subcutaneously at a clean, rotated site abdomen, thigh, or upper arm For how to manage any side effects during titration, see our [semaglutide side effects guide](/guides/semaglutide-side-effects-how-to-manage)

Accessed March 24, 2026

References [1] Johnson, M.K., et al

doi: 10.1007/s00125-024-06102-x

These results should have huge implications for Skyes stock price

J., Calder, R